Existing research has highlighted that Areg augments ERK1/2 activation in mature lung epithelial cells [63,64,65], aortic smooth muscle cells [66], bone tissues [67], keratinocytes [68], and breast [69] and pancreatic [70] cancer cells. The gene discussed is MAPK3; the disease is cancer.